[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 5023 followers
Created: 2025-07-22 19:22:21 UTC

A decade of progress in type X diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists - a comprehensive review $NVO $LLY $AZN $SNY 
$GSK $PFE $RHHBY $ZLDPF 
$VKTX $VANI $HIMS

![](https://pbs.twimg.com/card_img/1945963929747787776/hVILlWy8?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947739007556649170/c:line.svg)

**Related Topics**
[pfe](/topic/pfe)
[hims](/topic/hims)
[manat](/topic/manat)
[$hims](/topic/$hims)
[$vani](/topic/$vani)
[$zldpf](/topic/$zldpf)
[$rhhby](/topic/$rhhby)
[$gsk](/topic/$gsk)

[Post Link](https://x.com/AponiaAnalytics/status/1947739007556649170)